Sabra Healthcare REIT Reports Q3 Results and Upgraded Rating

Tip Ranks
2025.11.05 21:53
portai
I'm PortAI, I can summarize articles.

Sabra Healthcare REIT (SBRA) reported Q3 results with a net income of $0.09 per diluted share and a 13.3% increase in same-store managed senior housing Cash NOI year-over-year. The company raised $165 million through share issuance and received a Moody’s upgrade to ‘Baa3’ for its senior unsecured notes. Sabra updated its 2025 earnings guidance, projecting growth in its managed senior housing portfolio. Analysts rate SBRA stock as a Buy with a $20.00 price target, highlighting strong financial performance but noting some technical risks.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

The latest announcement is out from Sabra Healthcare REIT ( (SBRA) ).

On November 5, 2025, Sabra Healthcare REIT announced its third-quarter results, reporting a net income of $0.09 per diluted share and a notable increase in same-store managed senior housing Cash NOI by 13.3% year-over-year. The company acquired multiple senior housing properties and issued shares to raise capital, resulting in net proceeds of $165 million. Moody’s upgraded Sabra’s senior unsecured notes rating to ‘Baa3’, reflecting improved financial performance and a positive outlook for senior housing. Sabra updated its 2025 earnings guidance, projecting continued growth in its managed senior housing portfolio and exceeding its previous investment target of $500 million.

The most recent analyst rating on (SBRA) stock is a Buy with a $20.00 price target. To see the full list of analyst forecasts on Sabra Healthcare REIT stock, see the SBRA Stock Forecast page.

Spark’s Take on SBRA Stock

According to Spark, TipRanks’ AI Analyst, SBRA is a Outperform.

Sabra Healthcare REIT’s overall score is driven by its solid financial performance and strong earnings call insights. The company’s robust cash flow and high dividend yield are significant strengths. However, technical indicators suggest a bearish trend, and challenges in portfolio transitions present risks. The valuation is moderate, making it an attractive option for income-focused investors.

To see Spark’s full report on SBRA stock, click here.

More about Sabra Healthcare REIT

Sabra Healthcare REIT, Inc. is a real estate investment trust that focuses on investing in healthcare-related real estate properties. As of September 30, 2025, Sabra’s portfolio includes 363 real estate properties across the United States and Canada, comprising skilled nursing facilities, senior housing communities, behavioral health facilities, and specialty hospitals.

Average Trading Volume: 2,642,844

Technical Sentiment Signal: Buy

Current Market Cap: $4.31B

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer